Microbiome researcher, DuPont Nutrition & Biosciences
Henna-Maria Uusitupa investigates innovative solutions to minimize health risks that infants might have due to disruptions in microbiota development. Devoting her post-doctoral career to understanding the programming effects of early life nutrition on infant metabolic, cognitive and microbiota development, currently Uusitupa is working at DuPont Nutrition and Biosciences as a Senior Scientist and Technical Lead of Infant Health Platform based in Kantvik, Finland. She has one clear goal in her mind: to find the right product combination to restore the microbiota of infants after disruptions.
In 2017, DuPont launched the Microbiome Venture, a small and focused entrepreneurial team with a strong connection to the entire DuPont organization. Through strategic partnerships and investments in research and development, the Microbiome Venture will complement and build upon DuPont’s existing leadership in the areas of probiotics and prebiotics, including human milk oligosaccharides (HMOs), to deliver microbiome-science-based products and solutions.
Transformation begins with the spark of something new.
In 2018, TED and DuPont began a partnership to do just that: TRANSFORM. As the world and our interactions grow more complex, so do our challenges. To solve for modern problems, we decided to pursue a new framework for innovation itself, one that considers all perspectives and outcomes in the calculus. This inaugural TED@DuPont event signifies a monumental step to unlock the institutional knowledge within the organization and showcase the New DuPont. Taking place in September 2019, at The Fillmore in Philadelphia, the day’s topics ranged from science, technology, and beyond. Photo: Ryan Lash / TED